Stock listing
KK3A Stock Price, News, Filings & Events — Cytokinetics, Incorporated
Selected listing: KK3A · SWB · EUR · DE
This page tracks Cytokinetics, Incorporated's KK3A:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KK3A:SWB. KK3A:SWB is the stock-level entry point for investors researching Cytokinetics, Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytokinetics, Incorporated (Ticker: CYTK) is a public company based in the United States with a market capitalization of approximately $9.98 billion. The company focuses on developing innovative treatments for serious diseases, particularly in the fields of muscle biology and neuromuscular disorders. Cytokinetics is committed to advancing its research and product pipeline to improve patient outcomes.
- Ticker
- KK3A:SWB
- Asset type
- Stock
- Market cap
- $9.56B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SWB
- Currency
- EUR
Cytokinetics, Incorporated KK3A:SWB stock context
This page tracks Cytokinetics, Incorporated's KK3A:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KK3A:SWB. KK3A:SWB is the stock-level entry point for investors researching Cytokinetics, Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytokinetics, Incorporated (Ticker: CYTK) is a public company based in the United States with a market capitalization of approximately $9.98 billion. The company focuses on developing innovative treatments for serious diseases, particularly in the fields of muscle biology and neuromuscular disorders. Cytokinetics is committed to advancing its research and product pipeline to improve patient outcomes.
Latest news from Cytokinetics, Incorporated
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
September 14, 2026
Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
August 29, 2026
Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
August 20, 2026
Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales
July 30, 2026
Cytokinetics, Incorporated earnings calls
Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Cytokinetics, Incorporated (CYTK) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call
February 24, 2026 · Replay with transcript and chapters
Cytokinetics, Incorporated (CYTK) Q4 2026 Earnings Call
February 24, 2026 · Replay with transcript and chapters
Cytokinetics, Incorporated (CYTK) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Research Cytokinetics, Incorporated
Cytokinetics, Incorporated investor report
Review AI stock analysis and investor report context for KK3A:SWB.
Cytokinetics, Incorporated company profile
View the public company page for Cytokinetics, Incorporated on 6ix.
Cytokinetics, Incorporated news
Read company news and market updates connected to Cytokinetics, Incorporated.
Cytokinetics, Incorporated investor events
Find investor webinars, events, and replay context for Cytokinetics, Incorporated.
Alternate listings
CYTK:NASDAQ
US · USD
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
KK3A:GETTEX
DE · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
A1W1KK:LSX
DE · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
A1W1KK:LS
DE · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
CYTK:BOATS
US · USD
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
KK3A:TRADEGATE
DE · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
1CYTK:MIL
IT · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
KK3A:FWB
DE · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
KK3A:BX
CH · CHF
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
KK3A:DUS
DE · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
KK3A:HAM
DE · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.
KK3A:MUN
DE · EUR
Alternate listing for Cytokinetics, Incorporated; the primary context on this page is KK3A:SWB.